# Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)

> **NCT03981289** · — · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 116 (actual)

## Conditions studied

- Limb Girdle Muscular Dystrophy
- Muscular Dystrophies

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03981289
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-14
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03981289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03981289, "Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03981289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*